Beijing Tongrentang Co Ltd (600085) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills.

Total Cash From Operating Activities Chart for Beijing Tongrentang Co Ltd

Beijing Tongrentang Co Ltd (600085) operating cash flow for FY2025 was CNY 2.7B, a 253.9% change from FY2024. Beijing Tongrentang Co Ltd's operating cash flow grew from CNY 145.0M in 1998 to CNY 2.7B in 2025 (1757.6% over 27 years). Operating cash flow compound annual growth rate: 5-year CAGR of 4.4%, 10-year CAGR of 12.5%, 20-year CAGR of 14.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.